跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irinotesin Concentrate for Solution for Infusion 20mg/ ml - HSA Drug Approval Details
Approvals
/
HSA
/
Irinotesin Concentrate for Solution for Infusion 20mg/ ml
Approved
STANDARD
Irinotesin Concentrate for Solution for Infusion 20mg/ ml
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
905c9abee04a869a
Company
Unknown
Type
Standard
Approval Details
Approval Id
905c9abee04a869a
Drug Name
Irinotesin Concentrate for Solution for Infusion 20mg/ ml
Active Ingredients
Irinotecan Hydrochloride Trihydrate
20mg/ ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
905c9abee04a869a
Type
Standard
Back to HSA Approvals
